Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 - PubMed (original) (raw)
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
K Qing et al. Nat Med. 1999 Jan.
Abstract
Adeno-associated virus 2 (AAV)-based vectors have gained attention as a potentially useful alternative to the more commonly used retroviral and adenoviral vectors for human gene therapy. Although AAV uses the ubiquitously expressed cell surface heparan sulfate proteoglycan (HSPG) as a receptor, the transduction efficiency of AAV vectors varies greatly in different cells and tissues in vitro and in vivo. We demonstrate here that cell surface expression of HSPG alone is insufficient for AAV infection, and that AAV also requires human fibroblast growth factor receptor 1 (FGFR1) as a co-receptor for successful viral entry into the host cell. We document that cells that do not express either HSPG or FGFR1 fail to bind AAV and, consequently, are resistant to infection by AAV. These non-permissive cells are successfully transduced by AAV vectors after stable transfections with cDNAs encoding the murine HSPG and the human FGFR1. Furthermore, AAV infection of permissive cells, known to express both FGFR1 and the epidermal growth factor receptor, is abrogated by treatment of cells with basic fibroblast growth factor, but not with epidermal growth factor. The identification of FGFR1 as a co-receptor for AAV should provide new insights not only into its role in the life cycle of AAV, but also in the optimal use of AAV vectors in human gene therapy.
Comment in
- Adeno-associated virus 2 co-receptors?
Qiu J, Mizukami H, Brown KE. Qiu J, et al. Nat Med. 1999 May;5(5):467-8. doi: 10.1038/8328. Nat Med. 1999. PMID: 10229209 No abstract available.
Similar articles
- AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
Summerford C, Bartlett JS, Samulski RJ. Summerford C, et al. Nat Med. 1999 Jan;5(1):78-82. doi: 10.1038/4768. Nat Med. 1999. PMID: 9883843 - CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.
Kurzeder C, Koppold B, Sauer G, Pabst S, Kreienberg R, Deissler H. Kurzeder C, et al. Int J Mol Med. 2007 Feb;19(2):325-33. Int J Mol Med. 2007. PMID: 17203208 - Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
Nicklin SA, Buening H, Dishart KL, de Alwis M, Girod A, Hacker U, Thrasher AJ, Ali RR, Hallek M, Baker AH. Nicklin SA, et al. Mol Ther. 2001 Sep;4(3):174-81. doi: 10.1006/mthe.2001.0424. Mol Ther. 2001. PMID: 11545607 - Structural and cellular biology of adeno-associated virus attachment and entry.
Zengel J, Carette JE. Zengel J, et al. Adv Virus Res. 2020;106:39-84. doi: 10.1016/bs.aivir.2020.01.002. Epub 2020 Feb 13. Adv Virus Res. 2020. PMID: 32327148 Review. - In vivo tissue-tropism of adeno-associated viral vectors.
Srivastava A. Srivastava A. Curr Opin Virol. 2016 Dec;21:75-80. doi: 10.1016/j.coviro.2016.08.003. Epub 2016 Sep 3. Curr Opin Virol. 2016. PMID: 27596608 Free PMC article. Review.
Cited by
- Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
Wagner HJ, Weber W, Fussenegger M. Wagner HJ, et al. Adv Sci (Weinh). 2021 Feb 26;8(9):2004018. doi: 10.1002/advs.202004018. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 33977059 Free PMC article. Review. - Adeno-associated virus: from defective virus to effective vector.
Gonçalves MA. Gonçalves MA. Virol J. 2005 May 6;2:43. doi: 10.1186/1743-422X-2-43. Virol J. 2005. PMID: 15877812 Free PMC article. Review. - Virus-based gene delivery systems.
Mah C, Byrne BJ, Flotte TR. Mah C, et al. Clin Pharmacokinet. 2002;41(12):901-11. doi: 10.2165/00003088-200241120-00001. Clin Pharmacokinet. 2002. PMID: 12222993 Review. - Hot topics in adeno-associated virus as a gene transfer vector.
Zhao N, Liu DP, Liang CC. Zhao N, et al. Mol Biotechnol. 2001 Nov;19(3):229-37. doi: 10.1385/MB:19:3:229. Mol Biotechnol. 2001. PMID: 11721619 Review. - Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. Warrington KH Jr, et al. J Virol. 2004 Jun;78(12):6595-609. doi: 10.1128/JVI.78.12.6595-6609.2004. J Virol. 2004. PMID: 15163751 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous